Novabay Pharmaceuticals Inc Revenue Q/Q
What is the Revenue Q/Q of Novabay Pharmaceuticals Inc?
The Revenue Q/Q of Novabay Pharmaceuticals Inc is -47.94%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on NYSEMKT compared to Novabay Pharmaceuticals Inc
What does Novabay Pharmaceuticals Inc do?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Companies with revenue q/q similar to Novabay Pharmaceuticals Inc
- Future Supply Chain Solutions has Revenue Q/Q of -48.03%
- Grand Gulf has Revenue Q/Q of -48.03%
- Organovo Inc has Revenue Q/Q of -48.00%
- Tata Motors has Revenue Q/Q of -47.97%
- Ganfeng Lithium Co has Revenue Q/Q of -47.96%
- Kanoria Chemicals & Industries has Revenue Q/Q of -47.95%
- Novabay Pharmaceuticals Inc has Revenue Q/Q of -47.94%
- Satu has Revenue Q/Q of -47.86%
- Eaton Vance Short Duration Diversified Income Fund has Revenue Q/Q of -47.85%
- Manfield Chemical has Revenue Q/Q of -47.85%
- ShaMaran Petroleum has Revenue Q/Q of -47.83%
- Fluence has Revenue Q/Q of -47.82%
- Noble has Revenue Q/Q of -47.76%